Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent.

Dalos D, Gangl C, Roth C, Krenn L, Scherzer S, Vertesich M, Lang I, Maurer G, Neunteufl T, Berger R, Delle-Karth G.

BMC Cardiovasc Disord. 2016 May 25;16:104. doi: 10.1186/s12872-016-0296-1.

2.

Restenosis after coronary spasm in a bioresorbable vascular scaffold.

Dalos D, Vertesich M, Jakowitsch J, Lang IM.

Coron Artery Dis. 2016 Mar;27(2):159-61. doi: 10.1097/MCA.0000000000000330. No abstract available.

PMID:
26751422
3.

Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography.

Pichler P, Pichler-Cetin E, Vertesich M, Mendel H, Sochor H, Dock W, Syeda B.

Am J Cardiol. 2012 Jan 15;109(2):169-73. doi: 10.1016/j.amjcard.2011.08.025.

PMID:
22011557
4.

Two-dimensional speckle-tracking strain echocardiography in long-term heart transplant patients: a study comparing deformation parameters and ejection fraction derived from echocardiography and multislice computed tomography.

Syeda B, Höfer P, Pichler P, Vertesich M, Bergler-Klein J, Roedler S, Mahr S, Goliasch G, Zuckermann A, Binder T.

Eur J Echocardiogr. 2011 Jul;12(7):490-6. doi: 10.1093/ejechocard/jer064.

5.

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD; PLATINUM Trial Investigators..

J Am Coll Cardiol. 2011 Apr 19;57(16):1700-8. doi: 10.1016/j.jacc.2011.02.016.

Supplemental Content

Loading ...
Support Center